Provided by Tiger Trade Technology Pte. Ltd.

Gossamer Bio Inc.

0.1597
-0.0202-11.23%
Pre-market: 0.1548-0.0049-3.07%04:25 EDT
Volume:23.67M
Turnover:3.74M
Market Cap:78.09M
PE:-0.25
High:0.1723
Open:0.1500
Low:0.1499
Close:0.1799
52wk High:3.87
52wk Low:0.1138
Shares:489.00M
Float Shares:306.00M
Volume Ratio:3.50
T/O Rate:7.74%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6496
EPS(LYR):-0.7455
ROE:-783.37%
ROA:-62.39%
PB:-0.83
PE(LYR):-0.21

Loading ...

Gossamer Bio Announces 1-for-80 Reverse Stock Split

THOMSON REUTERS
·
Yesterday

Gossamer Bio Highlights Seralutinib Phase 3 Prosera Data, Targets PAH NDA Filing

Reuters
·
Sep 08

Gossamer Bio to Present at Cantor Global Healthcare Conference

Reuters
·
Sep 04

Gossamer Bio - Board Approves Amendment and Restatement of Bylaws Effective Sept 3, 2026 - SEC Filing

THOMSON REUTERS
·
Sep 04

Gossamer Bio Cuts Shareholder Meeting Quorum Requirement to One-Third of Voting Power

Reuters
·
Sep 04

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Gossamer Bio (GOSS) and Biohaven Ltd. (BHVN)

TIPRANKS
·
Aug 27

NASD Most Active Issues

Dow Jones
·
Aug 22

Gossamer Bio Agrees to Up to $250 Million Private Placement; Shares Rise Pre-Bell

MT Newswires Live
·
Aug 21

Gossamer Bio, - Proceeds Expected to Fund Operations into 2028

THOMSON REUTERS
·
Aug 21

Gossamer Bio, - $25 Mln Funded at Initial Closing, $125 Mln upon FDA Nda Acceptance

THOMSON REUTERS
·
Aug 21

Gossamer Bio Announces up to $250 Million Structured Private Placement, Including $150 Million of Committed Capital, to Fund Seralutinib Through Potential FDA Approval

THOMSON REUTERS
·
Aug 21

Guggenheim Remains a Hold on Gossamer Bio (GOSS)

TIPRANKS
·
Aug 14

Gossamer Bio Q2 EPS $(0.08) Beats $(0.12) Estimate, Sales $9.238M Beat $5.193M Estimate

Benzinga Earnings
·
Aug 14

Gossamer Bio Q2 FY26 Returns to Profit at $16.9 Million; Revenue Falls 19.6% to $9.24 Million

Reuters
·
Aug 14

OTLK, HBAN, CORT, CAPR, GOSS Trending With Analysts

TIPRANKS
·
Aug 01

Gossamer Bio Inc Expected to Post a Loss of 12 Cents a Share - Earnings Preview

Reuters
·
Aug 01

Gossamer Bio (GOSS) Receives a Hold from Wedbush

TIPRANKS
·
Jul 29

Leerink Partners Upgrades Gossamer Bio to Outperform From Market Perform, $1 Price Target

MT Newswires Live
·
Jul 28

Top Premarket Gainers

MT Newswires Live
·
Jul 28

U.S. Research Roundup- BioLife Solutions, Gossamer Bio, Intuit

Reuters
·
Jul 28